NCT02057458View on ClinicalTrials.gov

Blood Flow and Vascular Function in Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

Sildenafil (Acute-1 hour)

Vascular function will be assessed 1 hour following oral ingestion of sildenafil (50 mg)

DRUG

Sildenafil (Subchronic-4 weeks)

Vascular function will be assessed 4 weeks following 20 mg three times per day (TID) of sildenafil for four weeks

DRUG

Placebo

Sugar pill designed to mimic the sildenafil treatment

Trial Locations (1)

30912

Augusta University, Augusta

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Augusta University

OTHER

NCT02057458 - Blood Flow and Vascular Function in Cystic Fibrosis | Biotech Hunter | Biotech Hunter